UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models

PloS one, 2020-06, Vol.15 (6), p.e0234268-e0234268

2020

Volltextzugriff (PDF)

Revisiting the Role of Glycosylation in the Structure of Human IgG Fc

ACS chemical biology, 2012-09, Vol.7 (9), p.1596-1602

2012

Volltextzugriff (PDF)

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells

Cellular & molecular immunology, 2016-05, Vol.13 (3), p.391-400

2016

Volltextzugriff (PDF)

Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen

PloS one, 2016-06, Vol.11 (6), p.e0157788-e0157788

2016

Volltextzugriff (PDF)

Correction: Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models

PloS one, 2021-05, Vol.16 (5), p.e0252060-e0252060

2021

Volltextzugriff (PDF)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Annals of the rheumatic diseases, 2019-02, Vol.78 (2), p.228-237

2019

Volltextzugriff (PDF)

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding

mAbs, 2015-07, Vol.7 (4), p.743-751

2015

Volltextzugriff (PDF)

An antidote approach to reduce risk and broaden utility of antibody-based therapeutics

The Journal of biological chemistry, 2017-05, Vol.292 (20), p.8498-8506

2017

Volltextzugriff (PDF)

Conformational changes of glucose/galactose‐binding protein illuminated by open, unliganded, and ultra‐high‐resolution ligand‐bound structures

Protein science, 2007-06, Vol.16 (6), p.1032-1041

2007

Volltextzugriff (PDF)

Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

mAbs, 2021-01, Vol.13 (1)

2021

Volltextzugriff (PDF)

pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling

The Journal of biological chemistry, 2015-02, Vol.290 (7), p.4282-4290

2015

Volltextzugriff (PDF)

Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis

Communications biology, 2019-03, Vol.2 (1), p.92-92, Article 92

2019

Volltextzugriff (PDF)

Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs

ACS chemical biology, 2020-04, Vol.15 (4), p.830-836

2020

Volltextzugriff (PDF)

An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability

Journal of pharmaceutical sciences, 2017-04, Vol.106 (4), p.1008-1017

2017

Volltextzugriff (PDF)

Non-carbohydrate Inhibitors of the Lectin DC-SIGN

Journal of the American Chemical Society, 2007-10, Vol.129 (42), p.12780-12785

2007

Volltextzugriff (PDF)

Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension

Bioconjugate chemistry, 2019-04, Vol.30 (4), p.1232-1243

2019

Volltextzugriff (PDF)

Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.604-609

2010

Volltextzugriff (PDF)

Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport

Journal of controlled release, 2018-06, Vol.279, p.126-135

2018

Volltextzugriff (PDF)

Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention

Molecular pharmaceutics, 2020-02, Vol.17 (2), p.507-516, Article acs.molpharmaceut.9b00939

2020

Volltextzugriff (PDF)

Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform

Cancer research communications, 2022-03, Vol.2 (3), p.146-157

2022

Volltextzugriff (PDF)

Ligand Binding and Substrate Discrimination by UDP-Galactopyranose Mutase

Journal of molecular biology, 2009-08, Vol.391 (2), p.327-340

2009

Volltextzugriff (PDF)

Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies

JCI insight, 2018-06, Vol.3 (12)

2018

Volltextzugriff (PDF)

The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan

mAbs, 2017-01, Vol.9 (1), p.104-113

2017

Volltextzugriff (PDF)

Structure-Based Design of a Periplasmic Binding Protein Antagonist that Prevents Domain Closure

ACS chemical biology, 2009-06, Vol.4 (6), p.447-456

2009

Volltextzugriff (PDF)

Monovalent IgG4 molecules: Immunoglobulin Fc mutations that result in a monomeric structure

mAbs, 2013-05, Vol.5 (3), p.406-417

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Berichte
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models

Revisiting the Role of Glycosylation in the Structure of Human IgG Fc

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells

Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen

Correction: Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding

An antidote approach to reduce risk and broaden utility of antibody-based therapeutics

Conformational changes of glucose/galactose‐binding protein illuminated by open, unliganded, and ultra‐high‐resolution ligand‐bound structures

Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling

Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis

Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs

An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability

Non-carbohydrate Inhibitors of the Lectin DC-SIGN

Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension

Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells

Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport

Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention

Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform

Ligand Binding and Substrate Discrimination by UDP-Galactopyranose Mutase

Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies

The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan

Structure-Based Design of a Periplasmic Binding Protein Antagonist that Prevents Domain Closure

Monovalent IgG4 molecules: Immunoglobulin Fc mutations that result in a monomeric structure

Suchergebnisse filtern